MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Motor Complications in Parkinson’s Disease

    E. Tharp, J. Martinez-Lemus, C. Onuigbo, T. Thomas, C. Green, J. Suescun, T. Le, E. Rodarte, R. Ritter Iii, T. Ellmore, M. Schiess (New York, USA)

    Objective: To evaluate the impact of intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) treatment on motor complications in Parkinson’s disease (PD). Background: Motor…
  • 2025 International Congress

    Combining Machine Learning and Linear Mixed Models to Estimate Medication Effect in People with Parkinson’s Disease

    A. Castro Mejia, S. Sapienza, L. Pavelka, R. Kruger, J. Klucken (Belvaux, Luxembourg)

    Objective: To estimate medication effect, as the score difference between MDS-UPDRS III in OFF and ON-state, using a minimal set of clinical features. Background: The…
  • 2025 International Congress

    Undescribed Variant of the THAP1 Gene Likely Pathogenic Associated with DYT6 – Case Report

    J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, D. Dos Santos, C. Habekost, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)

    Objective: To describe a case of dystonia DYT6 in which a variant of uncertain significance (VUS) in the THAP1 gene was found, which is likely…
  • 2025 International Congress

    Differentiated approach to treatment and diagnosis of Parkinson’s disease.

    ZUJ. Jahongir Qizi, RMA. Abduvahabovna (Fergana, Uzbekistan)

    Objective: The anatomical and physiological characteristics of tremor in patients with Parkinson’s disease and essential tremor at the same age significantly influence diagnostic approaches, differentiation…
  • 2025 International Congress

    A novel virtual home-safety fall prevention program for Parkinson’s Disease

    M. Afshari, V. Palakuzhy, G. Jones, A. Hernandez, B. Ouyang, C. Goetz (Chicago, USA)

    Objective: To determine the feasibility and preliminary efficacy of a novel virtually-delivered protocol targeting extrinsic environmental fall risk factors in the homes of persons with…
  • 2025 International Congress

    Mitigating Risk and Expanding Movement Disorder Specialist Capacity: Advancing Parkinson’s Disease Management with Integrated Monitoring, Targeted Triage and Improved Patient-Clinician Communication in Parkinson’s Disease.

    A. Arnold, T. Jansen, A. Hare, S. Shaffer, S. Khandhar, R. Gilron (San Francsico, USA)

    Objective: Empower patients with exercise-focused motivational frameworks and personalized tracking for real-time health insights, while reducing clinician burden through continuous monitoring and targeted health coaching—all…
  • 2025 International Congress

    Targeting inflammation and autophagy: a dual-inhibition strategy to reduce α-synuclein pathology in GBA1-associated Parkinson’s disease

    T. Usenko, A. Bezrukova, K. Basharova, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: To assess the effects of combined inhibition of mTOR (autophagy regulator) and STING (inflammation regulator) on α-synuclein phosphorylation, tyrosine hydroxylase expression, and lysosphingolipid levels in…
  • 2025 International Congress

    Treatment with Mucuna pruriens Plus Solo Carbidopa Prescription in Patient Reluctant to Initiation of Traditional Levodopa/Carbidopa Medication

    T. Denne (Mission Viejo, USA)

    Objective: To see if treatment with Mucuna pruriens 2 capsules (15% levodopa) TID, plus solo carbidopa prescription 25mg TID in patient reluctant to traditional levodopa/carbidopa management could help…
  • 2025 International Congress

    GPi Stimulation shows Immediate Effects in Motor Improvement within Pediatric Patients with Movement Disorders

    A. Brucker, A. Zakharova, S. Seyyed Mousavi, A. Salisbury, J. Olaya, M. Liker, T. Sanger (Orange, USA)

    Objective: This study was conducted in order to determine whether GPi stimulation has immediate clinical effect in patients with dystonia who underwent Deep Brain Stimulation…
  • 2025 International Congress

    Online Learning Preferences of Healthcare Providers Caring for People with Parkinson’s Disease

    A. Smiley, I. Blackwood, L. Hoffman, R. Miller, K. Fitzgerald, C. Gadala-Maria, E. Pollard, A. Paul (Miami, USA)

    Objective: This study aimed to identify the instructional preferences and barriers to continuing education (CE) participation and completion among healthcare professionals caring for people with…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley